| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.0M | — | -27.2% |
| R&D Expense | $2.0M | — | -34.2% |
| SG&A Expense | $9.5M | — | -41.7% |
| Operating Income | -$42.5M | — | -208.9% |
| Interest Expense | $3.4M | — | -34.5% |
| Pre-tax Income | -$43.8M | — | -921.5% |
| Income Tax | -$201K | — | -415.4% |
| Net Income | -$43.6M | — | -926.2% |
| EPS (Basic) | -$2.39 | — | -7866.7% |
| EPS (Diluted) | -$2.39 | — | -7866.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $23.8M | -2.0% | -42.9% |
| Short-term Investments | $2.0M | +0.5% | -55.7% |
| Accounts Receivable | $9.3M | -22.0% | -16.1% |
| Current Assets | $43.1M | -5.4% | -34.2% |
| Total Assets | $213.4M | -16.3% | -28.8% |
| Current Liabilities | $155.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.0M | — | -8.1% |
| Investing Cash Flow | -$1.7M | — | -104.3% |
| Financing Cash Flow | -$1.8M | — | +93.6% |
| +205.0% |
| Long-term Debt | $123.2M | -4.1% | +4.4% |
| Total Liabilities | $188.6M | -2.4% | -4.9% |
| Stockholders' Equity | $24.8M | -60.0% | -74.9% |